CMS’ Oncology Care Model program is bringing bundled payments to cancer care. With drug costs so high and hard to control, the 195 participating practices will have to figure out other ways to control costs if they want to beat financial benchmarks and earn bonuses.
Current versions by ASCO, NCCN, and others may not be right for insurers, but they are eyeing new ways to crunch the numbers for cost and outcomes.
Experts are rethinking the routine cancer screen. In the future, screening recommendations may be tailored, risk-stratified, and based on our genes.
Patients and doctors are fighting the urge to rush in and treat cancer right away. Insurers must walk a fine line.
Legislation & Regulation: Campaign 2016
The fate of the health care reform law will be determined by the outcome of a joyless election.
Paul Lendner ist ein praktizierender Experte im Bereich Gesundheit, Medizin und Fitness. Er schreibt bereits seit über 5 Jahren für das Managed Care Mag. Mit seinen Artikeln, die einen einzigartigen Expertenstatus nachweisen, liefert er unseren Lesern nicht nur Mehrwert, sondern auch Hilfestellung bei ihren Problemen.
